Related Experiment Video
Updated: Jun 5, 2026
Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
Molecular profiling to identify relevant immune resistance mechanisms in the tumor microenvironment
Thomas F Gajewski1, Mercedes Fuertes, Robbert Spaapen
1The University of Chicago, Chicago, IL 60636, USA. tgajewsk@medicine.bsd.uchicago.edu
Abstract:
The molecular identification of tumor antigens initially catalyzed substantial enthusiasm for the development of tumor antigen-based vaccines for the treatment of cancer. However, numerous vaccine approaches in melanoma and other cancers have yielded a low rate of clinical response, despite frequent induction of specific T cells as detected in the peripheral blood. This observation has prompted several investigators to begin interrogating the tumor microenvironment for biologic correlates to tumor response versus resistance. Evidence is beginning to emerge suggesting that distinct subsets of tumors may exist that reflect distinct categories of immune escape. Lack of chemokine-mediated trafficking, poor innate immune cell activation, and the presence of specific immune suppressive mechanisms can be found to characterize subsets of tumors. A non-inflamed tumor phenotype may predict for resistance to cancer vaccines, suggesting a possible predictive biomarker and patient enrichment strategy. But in addition, characterization of these subsets may pave the way for catering therapeutic interventions toward the biologic features of the tumor in individual patients.
Insights
Cancer vaccines often fail despite T cell induction. Investigating the tumor microenvironment reveals distinct immune escape mechanisms, with non-inflamed tumors predicting resistance to cancer vaccines.
Area of Science:
- Oncology
- Immunology
- Cancer Research
Background:
- Tumor antigen-based vaccines initially showed promise for cancer treatment.
- Many cancer vaccine trials, particularly in melanoma, have shown limited clinical response rates.
- This discrepancy highlights the need to understand factors beyond T cell response within the tumor microenvironment.
Purpose of the Study:
- To investigate the tumor microenvironment for biological factors correlating with cancer vaccine response or resistance.
- To identify distinct tumor subsets characterized by specific immune escape mechanisms.
- To explore the potential of tumor phenotype as a predictive biomarker for cancer vaccine efficacy.
Main Methods:
- Analysis of tumor microenvironment characteristics in relation to vaccine response.
- Identification of immune escape mechanisms including chemokine trafficking, innate immune cell activation, and immunosuppressive factors.
- Characterization of tumor phenotypes, specifically non-inflamed versus inflamed.
Main Results:
- Distinct tumor subsets exhibiting different immune escape strategies have been identified.
- Lack of chemokine-mediated trafficking, impaired innate immune cell activation, and presence of immunosuppressive mechanisms characterize resistant tumors.
- A non-inflamed tumor phenotype appears to predict resistance to current cancer vaccine strategies.
Conclusions:
- The tumor microenvironment plays a critical role in cancer vaccine failure.
- Tumor subsets with specific immune escape mechanisms can be identified.
- A non-inflamed tumor phenotype may serve as a predictive biomarker for patient selection in cancer vaccine trials.
- Tailoring therapeutic interventions based on individual tumor biology is a promising future direction.
